Daniel Wai‐Hung Ho

6.4k total citations · 3 hit papers
80 papers, 4.2k citations indexed

About

Daniel Wai‐Hung Ho is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Daniel Wai‐Hung Ho has authored 80 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Daniel Wai‐Hung Ho's work include Cancer Genomics and Diagnostics (11 papers), RNA modifications and cancer (10 papers) and Spine and Intervertebral Disc Pathology (8 papers). Daniel Wai‐Hung Ho is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), RNA modifications and cancer (10 papers) and Spine and Intervertebral Disc Pathology (8 papers). Daniel Wai‐Hung Ho collaborates with scholars based in Hong Kong, China and Finland. Daniel Wai‐Hung Ho's co-authors include Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong, Joyce Man‐Fong Lee, Chun‐Ming Wong, Pak C. Sham, Cheuk‐Ting Law, Lo‐Kong Chan, Lai Wei, Felice Ho‐Ching Tsang and Jaro Karppinen and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Daniel Wai‐Hung Ho

76 papers receiving 4.1k citations

Hit Papers

RNA N6‐methyladenosine methyltransferase‐like... 2009 2026 2014 2020 2017 2009 2021 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2
    2017 1.0k citations Daniel Wai‐Hung Ho, Joyce Man‐Fong Lee et al. Hepatology profile →
  2. Prevalence and Pattern of Lumbar Magnetic Resonance Imaging Changes in a Population Study of One Thousand Forty-Three Individuals
    2009 674 citations Kmc Cheung, Jaro Karppinen et al. profile →
  3. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
    2021 214 citations Daniel Wai‐Hung Ho, Yu‐Man Tsui et al. Nature Communications profile →

Peers

Daniel Wai‐Hung Ho
Chen Xu China
Wen Tan China
Koji Nakamura Japan
Ingrid Meulenbelt Netherlands
Victoria Johnson United Kingdom
John Loughlin United Kingdom
Aimin Li China
Jianhua Lin China
Jean Y. Tang United States
Chen Xu China
Daniel Wai‐Hung Ho
Citations per year, relative to Daniel Wai‐Hung Ho Daniel Wai‐Hung Ho (= 1×) peers Chen Xu

Countries citing papers authored by Daniel Wai‐Hung Ho

Since Specialization
Citations

This map shows the geographic impact of Daniel Wai‐Hung Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wai‐Hung Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wai‐Hung Ho more than expected).

Fields of papers citing papers by Daniel Wai‐Hung Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wai‐Hung Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wai‐Hung Ho. The network helps show where Daniel Wai‐Hung Ho may publish in the future.

Co-authorship network of co-authors of Daniel Wai‐Hung Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wai‐Hung Ho. A scholar is included among the top collaborators of Daniel Wai‐Hung Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wai‐Hung Ho. Daniel Wai‐Hung Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Luqing, Karen Man‐Fong Sze, Lü Tian, et al.. (2025). GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC. Hepatology. 83(4). 735–752. 1 indexed citations
3.
4.
5.
6.
7.
Ho, Daniel Wai‐Hung, et al.. (2024). Unraveling the tumor-initiating cells in hepatocellular carcinoma. Cancer Cell. 42(12). 1990–1993. 1 indexed citations
8.
Chiu, Yung‐Tuen, Karen Man‐Fong Sze, Daniel Wai‐Hung Ho, et al.. (2023). Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC. Hepatology. 78(5). 1368–1383. 9 indexed citations
9.
Zhang, Xin, et al.. (2023). Single-Cell Analysis of Primary Liver Cancer in Mouse Models. Cells. 12(3). 477–477. 2 indexed citations
10.
Cheung, Tan To, Daniel Wai‐Hung Ho, Qingyang Zhang, et al.. (2023). Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma. Liver Cancer. 13(1). 70–88. 7 indexed citations
11.
Huang, Hongyang, Yu‐Man Tsui, Daniel Wai‐Hung Ho, et al.. (2023). LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress. Hepatology. 79(2). 323–340. 7 indexed citations
12.
Ng, Irene Oi‐Lin, et al.. (2022). scAnalyzeR: A Comprehensive Software Package With Graphical User Interface for Single-Cell RNA Sequencing Analysis and its Application on Liver Cancer. Technology in Cancer Research & Treatment. 21. 2213884617–2213884617. 1 indexed citations
13.
Zhang, Qingyang, Daniel Wai‐Hung Ho, Yu‐Man Tsui, & Irene Oi‐Lin Ng. (2022). Single-Cell Transcriptomics of Liver Cancer: Hype or Insights?. Cellular and Molecular Gastroenterology and Hepatology. 14(3). 513–525. 9 indexed citations
14.
Chan, Lo‐Kong, Yu‐Man Tsui, Daniel Wai‐Hung Ho, & Irene Oi‐Lin Ng. (2021). Cellular heterogeneity and plasticity in liver cancer. Seminars in Cancer Biology. 82. 134–149. 81 indexed citations
15.
Liu, Bonnie Hei Man, Sze Keong Tey, Xiaowen Mao, et al.. (2021). TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis. Journal of Extracellular Vesicles. 10(10). e12135–e12135. 38 indexed citations
16.
Ho, Daniel Wai‐Hung, Yu‐Man Tsui, Lo‐Kong Chan, et al.. (2021). Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nature Communications. 12(1). 3684–3684. 214 indexed citations breakdown →
17.
Chan, Lo‐Kong, Daniel Wai‐Hung Ho, Irene Lo, et al.. (2020). RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma. Journal of Hepatology. 74(2). 360–371. 38 indexed citations
18.
Ho, Daniel Wai‐Hung, Lo‐Kong Chan, Mingjing Xu, et al.. (2016). TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication. Gut. 66(8). 1496–1506. 87 indexed citations
19.
Zeng, Yi, et al.. (2015). Fibroblast Growth Factor-Inducible 14: Multiple Roles in Tumor Metastasis. Current Molecular Medicine. 15(10). 892–904. 7 indexed citations
20.
Song, You‐Qiang, Kmc Cheung, Daniel Wai‐Hung Ho, et al.. (2008). Association of the Asporin D14 Allele with Lumbar-Disc Degeneration in Asians. The American Journal of Human Genetics. 82(3). 744–747. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chen Xu Breakdown of academic impact, for papers by Wen Tan Breakdown of academic impact, for papers by Koji Nakamura Breakdown of academic impact, for papers by Ingrid Meulenbelt Breakdown of academic impact, for papers by Victoria Johnson Breakdown of academic impact, for papers by John Loughlin Breakdown of academic impact, for papers by Aimin Li Breakdown of academic impact, for papers by Jianhua Lin Breakdown of academic impact, for papers by Jean Y. Tang
Rankless by CCL
2026